Paras Minhas, MD, PhD (@parasmin) 's Twitter Profile
Paras Minhas, MD, PhD

@parasmin

MD/PhD @Stanford. Intern @MSKCancerCenter. Incoming resident @HarvardRadOnc. @PDSoros Fellow & @MarshallScholar. Views are always my own.

ID: 3244014037

calendar_today13-06-2015 06:58:26

180 Tweet

343 Followers

830 Following

Felix Ehret (@felixehretmd) 's Twitter Profile Photo

Alzheimer's disease is one of the biggest medical challenges today. Effective treatment options are urgently needed. Could radiotherapy be a potential approach? Check our systematic review in IJROBP - The Red Journal ASTRO! tinyurl.com/4j5snfzp Alzheimer's Society Alzheimer's Association #RadOnc

Mara Bahri, MSc (@marabahri) 's Twitter Profile Photo

Kevin Lee, an MS4 The Ohio State University College of Medicine + newly matched into Neurology was diagnosed with a rare brain cancer in March of 2024. Since his diagnosis, he’s had a brain biopsy, multiple LPs, and just finished his first round of chemotherapy.

Mara Bahri, MSc (@marabahri) 's Twitter Profile Photo

Some friends of his, have created a GoFundMe to alleviate some of his financial burden. Any help is appreciated. Beyond that, please consider sharing Kevin’s story and supporting this future neurologist. 🧠 gofund.me/febcff4a

Dr. Melanie McReynolds (@dr_ohsopretty) 's Twitter Profile Photo

I’m so proud of the space we’ve been able to cultivate! A space where we can show up as our authentic selves and nerd out on science while discussing how we can change the world. Absolutely LOVE this community.

Eric Topol (@erictopol) 's Twitter Profile Photo

The metabolic dysfunction underpinning of #Alzheimer's disease and potential path to intervene by repurposing a drug class used in cancer (IDOI blockers) science.org/doi/10.1126/sc… Paras Minhas, MD, PhD science.org/doi/10.1126/sc… @LJohnsonLab @macauleylab Science Magazine

The metabolic dysfunction underpinning of #Alzheimer's disease and potential path to intervene by repurposing a drug class used in cancer (IDOI blockers)
science.org/doi/10.1126/sc…
<a href="/parasmin/">Paras Minhas, MD, PhD</a>
science.org/doi/10.1126/sc… 
@LJohnsonLab @macauleylab <a href="/ScienceMagazine/">Science Magazine</a>
Paras Minhas, MD, PhD (@parasmin) 's Twitter Profile Photo

Our initial work repurposing IDO1 inhibitors in phase I/II cancer trials for Alzheimer’s is now published! I am extremely grateful to all of our collaborators and everyone who contributed! doi.org/10.1126/scienc… The McReynolds Lab! Salk Institute Stanford Medicine Memorial Sloan Kettering Cancer Center

Dr. Melanie McReynolds (@dr_ohsopretty) 's Twitter Profile Photo

Very excited to share our work published in Science! In collaboration with Paras Minhas, MD, PhD and the Andreasson Lab at Stanford, we uncovered that modulating glucose metabolism through IDO1 inhibitors can restore cognition across Alzheimer’s pathologies! science.org/doi/10.1126/sc…

Maite Solas (@maitesolaszu) 's Twitter Profile Photo

Thrilled to announce that, finally, after a (very very) long way, our paper on the role of astrocytic GLUT1 in energy metabolism is published in Science Advances . science.org/doi/10.1126/sc… Want to know more about it? 👇👇

Harvard Radiation Oncology Program (@harvardradonc) 's Twitter Profile Photo

We are so excited to announce our incoming radiation oncology residents! Please give a warm welcome to the Class of 2030! #Match2025 #matchday #radonc

We are so excited to announce our incoming radiation oncology residents! Please give a warm welcome to the Class of 2030! #Match2025 #matchday #radonc
Michael Lin, MD PhD 🧬 (@michaelzlin) 's Twitter Profile Photo

Our NIH grant to discover coronavirus antiviral meds was terminated today. With this grant, we had developed a better SARSCoV2 inhibitor than Paxlovid, and we recently discovered an improved drug that looks better than Pfizer's own second-generation inhibitor.

Our NIH grant to discover coronavirus antiviral meds was terminated today.

With this grant, we had developed a better SARSCoV2 inhibitor than Paxlovid, and we recently discovered an improved drug that looks better than Pfizer's own second-generation inhibitor.
Yale Center for Research on Aging (Y-Age) (@yaleage) 's Twitter Profile Photo

“Immunometabolism Across Scales: From Cells to Systems to Healthspan” will be held Jan. 11-14, 2026 in Vancouver BC. Scientific organizers include Vishwa Deep Dixit of Yale School of Medicine. They meeting will explore the critical junction of metabolic & immune processes bit.ly/4nAdYYA

“Immunometabolism Across Scales: From Cells to Systems to Healthspan” will be held Jan. 11-14, 2026 in Vancouver BC. Scientific organizers include <a href="/VishwaDeepDixi1/">Vishwa Deep Dixit</a> of <a href="/YaleMed/">Yale School of Medicine</a>. They meeting will explore the critical junction of metabolic &amp; immune processes bit.ly/4nAdYYA
Henning Willers, MD, FASTRO (@henningwillers) 's Twitter Profile Photo

Excited to support #cancerresearch at Mass General Brigham Mass General Cancer Center - now more than ever‼️ Join us - run or walk!🏃🏃‍♂️🏃‍♀️🙏 🔥#RadOnc Linear Accelerators🔥 ➡️because.massgeneral.org/team/678075

Excited to support #cancerresearch at <a href="/MassGenBrigham/">Mass General Brigham</a> <a href="/MGHCancerCenter/">Mass General Cancer Center</a> - now more than ever‼️

Join us - run or walk!🏃🏃‍♂️🏃‍♀️🙏

🔥#RadOnc Linear Accelerators🔥
➡️because.massgeneral.org/team/678075